Frontier Medicines
Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transform patients’ lives.
81 employees · est. 2018 · South San Francisco, United...
Nimbus Therapeutics
We develop breakthrough medicines for patients through precision small molecule design.
99 employees · est. 2009 · Boston, United States
Nimbus Therapeutics is the older company (2018 vs 2009).
5 signals in the last 90 days
Side-by-Side Comparison
| Metric | Frontier Medicines | Nimbus Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2009 older |
| Headquarters | ||
| Headquarters | South San Francisco, United States | Boston, United States |
| Employees | ||
| Employees | 81 | 99 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Life Sciences | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series C | Private Equity |
| Total Funding | ||
| Total Funding | $255.50M | $637.00M |
| Funding Rounds | ||
| Funding Rounds | 5 | 9 |
| Services | ||
| Services | Covalent Drug Discovery, AI-Driven Chemoproteomics, Precision Medicine Development, Proteome Analysis | Target Selection, Drug Discovery, Translational Medicine, Clinical Development, Development of Small Molecule Medicines |
| Target Customers | ||
| Target Customers | Healthcare Providers, Biopharmaceutical Companies, Research Institutions, Investors in Life Sciences | Patients with Oncology Conditions, Patients with Immunological Disorders, Patients with Metabolic Indications, Biotechnology and Pharmaceutical Corporations, Healthcare Professionals |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Drug Discovery, Precision Medicine, Chemoproteomics, Covalent Drug Discovery, KRAS G12C, Oncology, Undruggable Proteins, Disease Drivers, Targeted Therapies, Computational Chemistry, Protein Binding Pockets, Small-molecule Drugs, Cancer Therapeutics | Precision Medicine, Small Molecule Design, Structure-based Drug Discovery, Computational Technologies, Machine Learning In Drug Development, Clinical-stage Therapeutics, Oncology, Immunology, Metabolic Diseases, Cancer Treatment, Autoimmune Conditions, HPK1 Inhibitor, WRN Program, Computational Chemistry |
| Website | ||
| Website | frontiermeds.com | nimbustx.com |
About Frontier Medicines
Frontier Medicines is a biopharmaceutical innovator transforming the landscape of drug discovery. Its mission to "drug the undruggable" is revolutionizing patient care by targeting disease-causing proteins once deemed untreatable. Founded in 2018, this precision medicine company operates from both S...
About Nimbus Therapeutics
Nimbus Therapeutics, founded in 2009, is a pioneering biotechnology company headquartered in the United States. The company is dedicated to developing breakthrough medicines through precision small molecule design, leveraging sophisticated computational technologies and machine learning-based predic...
We will tell you when either one moves
BounceWatch watches Frontier Medicines and Nimbus Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Frontier Medicines and Nimbus Therapeutics — by email.
Frequently Asked Questions
Compare Frontier Medicines with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Frontier Medicines on 20 Sep 2026, and Nimbus Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
